文献速递免疫规划

Strangvac:一种预防马链球菌兽疫亚种所致腺疫的重组融合蛋白疫苗

Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi.
PubMed 文献 · Vaccine · 2018-02-02

在马驹中开展三项研究,评估含八种蛋白的重组融合蛋白疫苗Strangvac 4的优化与保护效果。Strangvac 4接种组16匹马驹中仅3匹发热,而安慰剂对照组16匹全部发热(P<.001);Strangvac 4接种组8匹、对照组15匹从淋巴结回收马链球菌兽疫亚种(P=.016);Strangvac 4及其他原型疫苗均未出现不良反应;数据支持Strangvac 4疫苗进一步临床开发。

要点

  • Strangvac 4含CNE、SclC、SclF、SclI、EAG(融合为CCE)、SEQ_402、SEQ_0256(融合为Eq85)和IdeE八种蛋白。
  • Strangvac 4接种组16匹马驹中3匹发热,安慰剂对照组16匹全部发热(P<.001)。
  • Strangvac 4接种组8匹、对照组15匹从淋巴结回收马链球菌兽疫亚种(P=.016)。

核心结论

  • Strangvac 4原型多组分亚单位疫苗提供最佳保护,数据支持该疫苗进一步临床开发。

研究设计与样本

  • 三项研究,马驹接种重组融合蛋白组合以优化疫苗生产与保护水平。

主要发现

  • Strangvac 4接种组16匹马驹中3匹发热,安慰剂对照组16匹全部发热(P<.001)。
  • Strangvac 4接种组8匹、对照组15匹马驹从淋巴结回收马链球菌兽疫亚种(P=.016)。
  • Strangvac 4及其他原型疫苗接种后均未出现不良反应。

关键数值与推荐

  • Strangvac 4含八种蛋白:CNE、SclC、SclF、SclI、EAG(融合为CCE)、SEQ_402、SEQ_0256(融合为Eq85)和IdeE。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The host-restricted pathogen Streptococcus equi causes strangles in the horse, which is characterised by abscessation of the lymph nodes of the head and neck. The disease is endemic throughout the world causing considerable welfare and economic cost to the horse industry. Here we report the results of three studies where ponies were vaccinated with combinations of recombinant fusion proteins to optimise vaccine production and the level of protection conferred. Optimal protection was conferred by a prototype multicomponent subunit vaccine, Strangvac 4, which contained eight proteins CNE, SclC, SclF, SclI, EAG (fused as CCE), SEQ_402, SEQ_0256 (fused as Eq85) and IdeE. Across the three experiments only three of 16 ponies vaccinated with Strangvac 4 became pyretic compared to all 16 placebo-vaccinated control ponies (P < .001). S. equi was recovered from the lymph nodes of eight Strangvac 4-vaccinated and 15 control ponies (P = .016). None of the ponies vaccinated with Strangvac 4, or the other prototype vaccines developed adverse reactions following vaccination. Our data provide evidence in support of the further clinical development of the Strangvac 4 vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Robinson C, Frykberg L, Flock M, et al. Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi. Vaccine. 2018. PMID: 29398274. doi:10.1016/j.vaccine.2018.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。